HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen J Peterson Selected Research

Adiponectin

10/2023Pegozafermin Is a Potential Master Therapeutic Regulator in Metabolic Disorders: A Review.
5/2019Positive Effects of Heme Oxygenase Upregulation on Adiposity and Vascular Dysfunction: Gene Targeting vs. Pharmacologic Therapy.
1/2019Oxidized HDL, Adipokines, and Endothelial Dysfunction: A Potential Biomarker Profile for Cardiovascular Risk in Women with Obesity.
8/2012Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet.
5/2012High-fat diet exacerbates renal dysfunction in SHR: reversal by induction of HO-1-adiponectin axis.
7/2009The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice.
12/2008Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes.
8/2008L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice.
6/2008Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance.
5/2008Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen J Peterson Research Topics

Disease

22Obesity
05/2024 - 11/2003
13Insulin Resistance
05/2024 - 03/2002
9Inflammation (Inflammations)
05/2024 - 05/2010
8Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 03/2007
7Hypertension (High Blood Pressure)
05/2024 - 03/2002
5Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2020 - 12/2010
4Acute Coronary Syndrome
09/2023 - 05/2013
4Heart Failure
09/2023 - 05/2013
4Fibrosis (Cirrhosis)
06/2022 - 05/2019
4Hypertrophy
01/2021 - 05/2019
4Type 2 Diabetes Mellitus (MODY)
05/2019 - 12/2006
4Body Weight (Weight, Body)
03/2014 - 06/2008
4Weight Gain
08/2008 - 03/2002
3Atherosclerosis
04/2024 - 05/2010
3Wilms Tumor (Wilm's Tumor)
04/2023 - 06/2020
3Myocardial Infarction
01/2021 - 08/2013
3COVID-19
11/2020 - 06/2020
3Syncope (Fainting)
01/2016 - 01/2011
2Cardiomyopathies (Cardiomyopathy)
02/2024 - 05/2019
2Non-alcoholic Fatty Liver Disease
10/2023 - 01/2021
2Obstructive Sleep Apnea
04/2023 - 09/2017
2Fatty Liver
06/2022 - 03/2014
2Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 05/2012
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 05/2012
2Stroke (Strokes)
01/2021 - 01/2021
2Hemorrhage
01/2021 - 01/2021
2Cardio-Renal Syndrome
11/2020 - 08/2013
2Infections
11/2020 - 06/2020
2Metabolic Diseases (Metabolic Disease)
06/2020 - 09/2017
2Hyperglycemia
01/2017 - 12/2007
2Atrial Fibrillation
01/2011 - 01/2010
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2008 - 08/2007
1Dysbiosis
04/2024
1Hypertriglyceridemia
10/2023
1Inborn Genetic Diseases (Disease, Hereditary)
10/2023
1Hemochromatosis (Bronze Diabetes)
10/2023
1Infarction (Infarctions)
09/2023
1Heart Arrest (Cardiac Arrest)
09/2023
1Cardiac Edema
03/2023
1Ischemic Colitis
03/2023
1Cachexia
03/2023
1Liver Diseases (Liver Disease)
01/2022
1Heart Diseases (Heart Disease)
01/2021
1Cytokine Release Syndrome
07/2020
1Critical Illness (Critically Ill)
06/2020
1Thrombosis (Thrombus)
06/2020
1Hypoxia (Hypoxemia)
06/2020

Drug/Important Bio-Agent (IBA)

10AdiponectinIBA
10/2023 - 05/2008
10Proteins (Proteins, Gene)FDA Link
03/2023 - 12/2006
8Glucose (Dextrose)FDA LinkGeneric
06/2022 - 03/2002
8Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
01/2022 - 05/2008
7Heme Oxygenase-1IBA
01/2021 - 12/2007
6Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2016
6AdipokinesIBA
04/2023 - 01/2016
5LipidsIBA
01/2022 - 05/2012
4Insulin (Novolin)FDA Link
01/2022 - 03/2002
4CytokinesIBA
07/2020 - 06/2008
4EnzymesIBA
07/2020 - 06/2008
320-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
05/2024 - 01/2016
3fibroblast growth factor 21IBA
10/2023 - 03/2014
3LeptinIBA
01/2022 - 09/2006
3AntioxidantsIBA
01/2021 - 08/2007
3Insulin ReceptorIBA
07/2020 - 07/2009
3Heme (Haem)IBA
06/2020 - 05/2009
3cobaltiprotoporphyrinIBA
05/2019 - 12/2006
3Blood Glucose (Blood Sugar)IBA
08/2012 - 06/2008
3Reactive Oxygen Species (Oxygen Radicals)IBA
05/2009 - 12/2006
2Troponin IIBA
01/2022 - 01/2021
2omega-Chloroacetophenone (Mace)IBA
01/2021 - 01/2021
2erucylphosphocholineIBA
01/2021 - 01/2019
2Sirtuin 1IBA
06/2020 - 05/2019
2Angiotensin IIIBA
05/2019 - 08/2013
2Interleukin-6 (Interleukin 6)IBA
01/2019 - 08/2008
2Vasoconstrictor AgentsIBA
01/2016 - 01/2016
2Warfarin (Coumadin)FDA LinkGeneric
02/2011 - 01/2010
2Peptides (Polypeptides)IBA
05/2010 - 07/2009
1LigandsIBA
05/2024
1FatsIBA
04/2024
1LipopolysaccharidesIBA
04/2024
1ConnectinIBA
02/2024
1Triglycerides (Triacylglycerol)IBA
10/2023
1Apolipoprotein B-100 (Apo B 100)IBA
10/2023
1lipoprotein cholesterolIBA
10/2023
1IronIBA
10/2023
1SmokeIBA
09/2023
1CreatinineIBA
09/2023
1C-Reactive ProteinIBA
08/2023
1Nephroblastoma Overexpressed ProteinIBA
04/2023
1BilirubinIBA
01/2022
1PPAR gammaIBA
01/2021
1HDL CholesterolIBA
11/2020
1Charcoal (Charbon)IBA
11/2020
1Oxidants (Oxidizing Agents)IBA
11/2020
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
07/2020
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
07/2020
1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIBA
06/2020
1Twist-Related Protein 2IBA
06/2020

Therapy/Procedure

5Therapeutics
07/2020 - 03/2007
3Percutaneous Coronary Intervention
09/2023 - 01/2021
3Patient Readmission
01/2016 - 01/2011